The majority of laboratory injuries and exposures are
preventable, and most of them occur because staff is not paying close attention
to the situation. They lose their situational awareness or were never paying
attention to it from the start. Unfortunately, lab safety professionals spend
much of their time investigating such incidents rather than being able to
prevent them. If laboratory staff could understand the power of the pause, labs
would have fewer dangerous incidents.
One illustration of that power can be seen in a simple
exercise. A group of people is asked to read aloud quickly a list of words that
indicate different colors- green, red, etc. The words themselves, however, are
written in different colors, and the colors do not match the words. For
example, the word “red” is written in black, the word “blue” is written in
green, etc. This first part goes well, you’re just asking them to read the
actual words. Next, however, it gets harder. The people are asked to quickly go
down the list again, but this time they are asked to say the color of the word,
not that actual word. Typically, this does not go well. For the next step, the
exercise is repeated at a much slower pace, with a slight pause between each
word. Once a pause is placed between each word, the people recite the correct
colors. The incongruent words and colors creates what is known as the “Stroop
Effect,” first theorized in 1935, but pausing is a means of overcoming this
issue in our brains.
When investigating a needle stick incident, the lab safety
officer learned the employee completed the draw, attempted to engage the needle
safety device, but stuck their finger when grabbing the needle to toss it into
the sharps container. She did not notice the safety device did not engage and
the needle was still exposed. The employee stated she was busy and in a hurry
because there were many other patients waiting. I have always said that when a
lab employee is stressed and busy, that’s when stopping for a moment to gain
situational awareness is most important. Had this employee paused for a moment
to ensure the needle safety device was fully engaged, the incident would never
have occurred.
The lab manager had to speak to a chemistry tech after a
serum splash exposure to the eyes. When looking at the work area, the manager
noticed there was an adjustable face shield in place but that staff moved it
into place only when needed. The tech admitted he was busy at the time of the
splash and that he neglected to move the shield into place before uncapping
specimens. Again, a pause to think about safety here would have helped.
In another situation, a microbiology technologist was eager
to start the day and get it done since her vacation began the next day. She
quickly went through the daily checklist and checked items off but did not
actually perform the checks. Halfway through the day, she noticed it seemed
warm and that it was unusually quiet at her biological safety cabinet work
station. She decided to look at the gauges and noticed that there was no
protective air flow in operation. She had been working with TB samples all
morning. When she reported the issue, the manager told her that all employees
in the area would need to go to Employee Health and be followed up for TB
exposures. Pausing to perform the safety checks at the beginning of the shift
would have made a big difference in that outcome for several employees.
Pausing for safety in the laboratory setting can be a
powerful tool, even during the busiest moments. In fact, that’s when it works
best. Use that pause in your arsenal, and teach maintaining situational
awareness with your staff so that future injuries and exposures can be
prevented.
–Dan Scungio, MT(ASCP), SLS, CQA (ASQ) has over 25 years
experience as a certified medical technologist. Today he is the
Laboratory Safety Officer for Sentara Healthcare, a system of seven
hospitals and over 20 laboratories and draw sites in the Tidewater area
of Virginia. He is also known as Dan the Lab Safety Man, a lab safety consultant, educator, and trainer.
“Never, ever underestimate the importance of having fun,”
said Randy Pausch, a professor of computer science at Carnegie Mellon
University. Indeed, having fun is an important component of life, and that
includes your professional life. However, having fun in the workplace can seem
like an impossible task sometimes. There is, after all, lots of work to be
accomplished, performance to be measured, and projects to complete. This can
make it challenging to find of time and ways to have fun appropriately and
constructively.
The benefits of having fun in the workplace are plentiful. Because
most fun activities require people to work in groups or teams, the shared
experience can increase collaboration, engagement, and foster communication. Having
fun fosters motivation and commitment to an organization as people associate
the positive feelings and experiences with the workplace. This also increases
morale and comradery among the participants, which increases their performance.
All these aspects, in turn, foster creativity, innovative thinking, and
problem-solving skills. The more creative employees are, the more comradery
they feel among themselves, and the better they perform the more turnover is
reduced. Having fun in the workplace is incredibly beneficial to both the
employees and the organization overall.
In today’s workplace culture, people are generally more
aware and considerate of what is appropriate behavior. This also applies to
having fun, because if activities are only fun and enjoyable if they are
appropriate for everyone involved. It is, therefore, important to establish
clear boundaries: what is considered part of this activity and what is not. It
is also important to consider different levels of physical, mental, and
emotional ability. Having fun is inclusive and collaborative, so it is critical
to design activities that everyone can partake in. The activity should also
always be optional. Making participation mandatory is not actually fun for people,
so make sure that there is an opt-in and opt-out option. Finally, every
activity should have some element of learning and education. If you are asking
people to participate in a fun activity, ensure that they are learning
something about one another or about a specific topic.
There are many different ways in which you can incorporate
fun in the workplace. Last year at ASCP, our social committee hosted an ‘Oscar
Party” in which we could vote for our colleagues in categories such as “Outside
the Box Thinker/Innovator,”, “Outstanding Philanthropist,” and “Rookie of the
Year.” Then all staff gathered in the kitchen area of our office that was
decorated with a red carpet and we all received a glass of sparkling cider. The
winners were announced and cheered on as they walked the red carpet. They gave
a short speech after receiving their little Oscar award. It was a simple way to
have some collective fun and it felt so great cheering everyone on and
recognizing certain employees for their outstanding contribution to the society.
On average, babies laugh about 400 times a day. Adults, on the other hand, only laugh about 35 times a day and significantly less often on weekdays than on weekend (Beard, 2014). Laughter is incredibly important to our overall well-being and performance. In fact, “laughter relieves stress and boredom, boosts engagement and well-being, and spurs not only creativity and collaboration but also analytic precision and productivity”(Heggie, 2018). So, let’s try to incorporate more fun and more laughter in both our personal and our professional lives. Let’s find ways to cheer each other up and create a collaborative, warm, and productive environment that fosters engagement, retention, and analytic precision. After all, laughter is the best medicine.
-Lotte Mulder, EdM, is the Senior Manager of Organizational Leadership and Patient Engagement at ASCP. She earned her Masters of Education from the Harvard Graduate School of Education in 2013, where she focused on Leadership and Group Development. After she graduated, Lotte started her own consulting company focused on establishing leadership practices in organizations, creating effective organizational structures, and interpersonal coaching. She has worked in Africa, Latin America, Asia, and the U.S. on increasing leadership skills in young adults through cultural immersion, service learning and refugee issues, and cross-cultural interpretation. She is currently working toward a PhD in Organizational Leadership.
During the 2019 ASCP Annual Meeting in Phoenix, I noticed a
morning workshop session entitled “The Impact of Fun.” The title intrigued me,
so decided to take a break from the science and clinical medicine workshops
that I would normally attend, and take advantage of the opportunity to listen
in.
I have been working as a pathologist and lab director for 30
years, and while I hate to admit it, I had never thought seriously about taking
time during the day for playing games with my co-workers. I was always consumed
with meetings, deadlines, and getting the clinical work completed.
At the beginning of the course, I was a little unsure what I
had gotten myself into. However by the time the workshop concluded, the reality
of what I had been missing had set in.
When I returned to work following the meeting, I began to
search for fun activities that our lab team could do over a lunch hour. I set a
date and promised food to entice the wary into attending the event in the
conference room. Once they had assembled, I divided the group into two teams by
drawing an imaginary line down the middle of the room. We then played team trivia
using a book of questions I had acquired. By the end of the hour, everyone was
laughing and having fun. The lab continued to buzz with talk and occasional
laughter all afternoon.
We have continued setting aside one noon hour each month
where we gather for different types of games. Charades, and Pictionary have
been hits. Mostly everyone brings their own lunch, but food or deserts are
provided on occasion to keep these events special. There are a few who choose
not to participate, but even they occasionally show up to watch and laugh along
with the rest. As is pointed out above, you cannot make having fun a mandatory
or it ceases to be fun.
Our lab staff really seem to enjoy these events and so does
this old pathologist. During our most recent event, one of my young colleagues
remarked how much fun these lunches have been, and that they hoped we would
continue these going forward. I intend to keep these going as long as I
continue working. It has provided me with an opportunity to get to know each of
my co-workers much better. I only wish I had learned about the importance of
having fun with your co-workers and teammates earlier in my career. I encourage
other pathologists, lab directors and section supervisors to learn from my
experience and begin finding ways to bring the fun back into the workplace if
you have not already done so.
-Dr. Wisecarver is currently Professor Emeritus in the Department of Pathology/Microbiology at the University of Nebraska Medical Center in Omaha, Nebraska. He served as Medical Director of the Clinical Laboratories for Nebraska Medicine, their clinical affiliate from 1996 until 2017. He currently serves as the Director of the Histocompatibility Laboratory for Nebraska Medicine.
After a lot
of positive responses and sharing on social media, my article last month got lots of people talking about
annual meetings and how great they are for networking, learning, and advancing
our profession. Not too long after the ASCP Annual Meeting in Phoenix, I was
back in my Manhattan apartment working on my speech and graphics for a real
life TEDx session hosted at my medical school.
Let’s pause
here: if you either haven’t heard of the TED/TEDx brand or if you binge watch
their 18 minute videos and want more links to watch now, now, now!
TED
is a non-profit organization whose mission is to share “ideas worth spreading.”
They’re about 35 years old and based in NYC stateside, and Vancouver in Canada.
Basically, over the last few decades they hold conferences at those flagship
sites called “TED talks” where selected speakers present on a myriad of topics.
TEDx conferences are officially licensed but off-site events which operate
under TED protocol and guidelines. There have even been spin-off conferences
like TED MED, which focus solely on healthcare.
Image 1. What’s a TEDx talk? Basically, an off-site, officially sanctioned, “idea sharing” conference.
Some of the students at AUC School of Medicine, organized such a conference with official TED licensing and recruited me to join their list of speakers to deliver talks on their chosen theme: resilience. Officially called TEDxAUCMed, this conference included community members, students, artists, activists, and more discussing the human capacity for resilience in ways not commonly discussed. “Weathering the Storm” was the official event title, as the school located in the island nation of St. Maarten displays daily resilience especially since being hit by Hurricane Irma in 2016. Among their list of incredible speakers, I was humbled to be included! I titled my talk “Unrecognizable Medicine” and wanted to deliver a talk to students, clinicians, and those of us in medicine witnessing first-hand a tidal wave of new technologies and paradigms that redefine the way we discuss health. Oh, and since I’m a huge fan of #GraphicMedicine more and more each day, I hit that hashtag hard and decided to illustrate my whole talk!
Image 2. Title Card from my TEDx talk.
So what did I talk about, exactly…and what’s the big deal? I’m not going to re-hash my presentation for you in text—that’d be boring, and I’m obviously going to put a link at the bottom for you to watch it yourself. I got you, lab fam! But essentially, what I set up was a three-tiered template to assess and navigate that tidal wave of tech. Tools, skills, and strengths—three things inherent to the practice of medicine in any specialty.
Image 3. Red back-ligting. So intense. Thanks for coming to my TEDx Talk, literally!
There are
untapped topics in medicine which are looming over the horizon. As medicine
continues to evolve and change, the problems we face and the needs we must meet
will become moving targets. New specialties will emerge, and new technologies
will replace centuries old tools we cling to today. A shift in thinking is both
proactive and healthy in a profession that mandates our commitment to
preserving health and quality of life. I have spent years battling stereotypes
in medicine and hope to challenge the fabric that places individuals in
professional or academic boxes. Fresh first-years at some schools are already using
point-of-care ultrasounds (POCUSes) instead of stethoscopes—which
student sounds like they have better info on morning rounds, a student who
maybe kinda-sorta heard some non-descript murmur, or a mini-pocket
echocardiogram with an ejection fraction of 45%? Stereotypes have too long
shaped the way students choose specialties, equating some areas to colloquial
high school cliques! No offense to orthopedics or dermatology. Troponins used to be something you
could hang your white coat on, but not anymore. What do you do with a new 5th
generation Trop of 39 with a delta of 18? ACS or acute MI? Cancer therapy is
exploding with personalized treatments being added every day! Any student right
now would impress their heme/onc attending on rounds if they suggested PDL-1
and other immunotherapy testing for patients with newly diagnosed lung cancers.
*Deep breath*
Ok. My point
is, tomorrow’s medicine is going to have a lot of different therapies, tools,
and even vocabulary that schools may never catch up with. How do you prepare
for this explosion of knowledge? You look to yourself to take an inventory of
your strengths and use those to guide your clinical sails. Addressing
stereotypes head-on, learning on the spot, dealing with complex identities in
your patients, and always practicing with compassion will lend itself to
staying ahead and staying fulfilled.
Image 4. If you’re drawing cartoons of pathologists for an educational series, you probably make them look like you. Or in this case me, I guess. Keep an eye out for my #PathDoodles on social media!
Pretty heavy stuff right? But there’s something else that caught my attention in reflection on the TEDx talk… I’ve searched the TED library of videos, and while there are plenty of doctors, scientists, and pioneers in research discussing medical ideas, I haven’t seen any medical laboratory scientists. If you find any, please correct me. But, as I understand it, it’s just me. And that’s something special.
Image 5. My wife and I check-in for rehearsal at the TEDxAUCMed conference in sunny St. Maarten.
There’s a
culture shift in our profession, and a lot of us are talking about it.
Pathology and laboratory medicine are stepping out from behind the healthcare
curtain and asserting itself as a champion for patients, truth, and the
importance of data-driven medicine. Not only do I talk to groups of folks every
time I get a stage, but I use social media to reach clinicians and patients!
Yes, I’m one of few medical students-turned-residency applicants who didn’t
change their name to hide their online presence for the winter. But instead of
a secret twitter hibernation, I’ve used social media as a tool to network,
engage, and connect.
One of my
favorite new projects is something I call #PathDoodles where I break down the
aspects of pathology and some specialty topics for those outside of medicine
(and sometimes just outside our profession). I’ve already covered things like
“what is pathology?” and the importance of autopsies, the role of medical
laboratory scientists, and I continue to add more regularly!
Image 6. One of a growing list of #PathDoodles.
There’s a
culture shift in our profession, and a lot of us are talking about it.
Pathology and laboratory medicine are stepping out from behind the healthcare
curtain and asserting itself as a champion for patients, truth, and the
importance of data-driven medicine. Not only do I talk to groups of folks every
time I get a stage, but I use social media to reach clinicians and patients!
Yes, I’m one of few medical students-turned-residency applicants who didn’t
change their name to hide their online presence for the winter. But instead of
a secret twitter hibernation, I’ve used social media as a tool to network,
engage, and connect.
One of my
favorite new projects is something I call #PathDoodles where I break down the
aspects of pathology and some specialty topics for those outside of medicine
(and sometimes just outside our profession). I’ve already covered things like
“what is pathology?” and the importance of autopsies, the role of medical
laboratory scientists, and I continue to add more regularly!
Follow me on Twitter (@CEKanakisMD) and check out my TEDx talk:
My talk begins at 5:00:00. Enjoy!
–Constantine E. Kanakis MD, MSc, MLS (ASCP)CM completed his BS at Loyola University Chicago and his MS at Rush University. He writes about experiences through medical school through the lens of a medical lab scientist with interests in hematopathology, molecular, bioethics, transfusion medicine, and graphic medicine. He is currently a 2020 AP/CP Residency Applicant and actively involved in public health and education, advocating for visibility and advancement of pathology and lab medicine. Follow him on Twitter @CEKanakisMD
So far
we have reviewed the different federal regulatory agencies responsible for
establishing laboratory testing guidelines, a brief overview of the different
roles each department plays, as well as a discussion on testing complexity. In
today’s post we’ll cover the optional accreditations available to labs, and how
accreditation differs from certification.
In the
simplest of terms, certification is a mandatory requirement, whereas accreditation
is optional. Certification is required in order for laboratories to receive
payments from Medicare or Medicaid. Laboratories must meet the minimum
requirements set forth by CLIA to earn and maintain their certification status.
Accreditation
is an extra additional step that laboratories can take to set themselves apart
from neighboring labs by holding themselves to a higher standard. Accredited
laboratories must still adhere to the minimum CLIA requirements, but there are
additional rules and requirements to be satisfied depending upon the different
accreditation agencies.
More
rules and paperwork, why would anyone volunteer to take that on? Depending on
the size, complexity, and client population that your lab serves, the benefits
to obtaining accreditation can greatly outweigh the challenges of maintaining
that accreditation status.
One of
the requirements to maintaining your CLIA certification is routine inspections
to confirm compliance with the rules. Accreditation agencies require
inspections as well, but thankfully in most cases your CLIA inspection can be
satisfied by your accrediting agency; meaning your lab will receive a single
inspection to satisfy both groups. Results will vary for each lab, but
generally speaking the accreditation inspections are perceived to be easier to
get through than those conducted by the federal inspectors. For example, agencies
like The CAP and COLA tend to be more focused on sharing of ideas and good
laboratory practices, rather than coming in as the “lab police” and looking
only for problems. The explanation of their regulatory requirements tends to be
more user friendly and easier to interpret as well, rather than the formal CLIA
laws which are legal documents and read as such.
Recognition
by an accrediting agency confirms that the laboratory is qualified and
competent to perform testing for which it has received the accreditation for.
This stamp of approval can help patients and clients feel comfortable in
choosing your laboratory for their testing needs. For laboratories that perform
testing as part of clinical trial evaluations, this can help reduce the number
of requested on-site audits by the client themselves, as the client may choose
to rely on the third-party accreditation assessment due to their high
standards. It may also help encourage new clients to choose you for their
testing needs, as the accreditation confirms your commitment to higher quality
standards.
Another
possible benefit of having accreditation status is the impact on your laboratory
staff. Continually striving to raise the bar on your standards and going above
the bare minimum instills a sense of professionalism in your employees. By
continually reviewing the regulations and preparing for or responding to
inspections, staff are more likely to be committed to complying with your
organization’s quality management system and standards of performance. Staff
who are familiar with the requirements and the reasoning behind why a certain
task is performed or documented, are more likely to comply with those policies
and procedures.
There
are currently 7 CLIA approved accreditation agencies: https://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/Downloads/AOList.pdf. Some agencies are focused on a
specific discipline, such as AABB for transfusion medicine, and others are more
encompassing for all of the laboratory departments. Organizations looking to become accredited
should research each option in order to determine which ones would be best to
meet their specific needs. It is also common for labs to maintain more than one
accreditation at a time, for example AABB and CAP. As always, the regulatory
agency with the most stringent rules would be the ones the lab is expected to
adhere to. In cases of joint accreditation, multiple inspectors may be needed
to complete the biennial inspection; however the agencies will try to
coordinate efforts and work together so that the inspections occur
simultaneously. Sticking with our AABB & CAP example, CAP will work with
AABB to locate an AABB approved inspector for the transfusion medicine
checklist, while the remainder of the CAP inspection will be carried out by CAP
inspectors. The AABB inspector would then inspect the transfusion medicine
department for compliance with both CAP and AABB requirements at the same time.
The accreditation process may be challenging, but once you have obtained that esteemed status, the opportunities for continual education and improvement of your laboratory will be endless.
-Kyle Nevins, MS, MLS(ASCP)CM is one of ASCP’s
2018 Top 5 in the 40 Under Forty recognition program. She has worked in
the medical laboratory profession for over 18 years. In her current
position, she transitions between performing laboratory audits across
the entire Northwell Health System on Long Island, NY, consulting for
at-risk laboratories outside of Northwell Health, bringing laboratories
up to regulatory standards, and acting as supervisor and mentor in labs
with management gaps.
I’m writing to you now back in Manhattan after visiting
sunny Phoenix, AZ for this year’s ASCP Annual Meeting. Last month
I talked about downtime, pathology emergencies, and introduced you all to our
insightful and dynamic colleague, Jalissa Hall. It was great working with her
and one of the last things we talked about was getting to go to professional
society meetings. We also talked about the upcoming meeting next year in
Austin, TX! And that’s exactly what I’d like to talk about with you this time:
why going to meetings like ASCP is not only educational, but an excellent way
to network with your laboratorian peers from around the country.
Image 1a. My wife and I made it to the Phoenix Hyatt Regency on registration day! ASCP swag on, obviously.Image 1b. Behind the Scenes – Hosting the ASCP 2019 Facebook Live broadcast with two fantastic colleagues, Dr. K. Mirza and Dr. A. Booth! Did you catch us? But more about social media later…
I couldn’t go to every single session—there’s just too
many—but I did learn so much valuable, practical information at the educational
sessions. Here are just a mere few insights from the long list of fantastic
speakers I had the chance to visit!
I participated in an interactive session on the
ASCP/CAP/ASH guidelines for lymphoma workup…
Figure 1. All the multidisciplinary expertise must go through rigorous adjustment and evaluation all the way throughout the process of seeking out and publishing proper guidelines. (Source: ASCP 2019 session 5007-19; Kroft, S., Sever, C., and Cheung, M.)
Drs. Kroft, Sever, and Cheung discussed updates from the WHO
2016 guidelines as well as relating any changes in concurrent literature to
appropriate diagnostic accuracy with evidence-based guidelines. If it sounds
familiar, it’s because I talked about these guidelines a
few months ago! In my month clerkship at The Mayo Clinic in Rochester, MN I
presented a therapy-related AML case in the setting of Li-Fraumeni disorder. In
my discussion I stressed the utility and importance of having organized and
algorithmic guidelines to diagnose patients accurately, effectively, and
timely. This time, instead of just talking about the guidelines, I got to
listen to some of the folks who actually put them together—and,
according to them, it’s no easy task!
I learned about culturally appropriate leadership
training…
Figure 2. The panelists each had something insightful and moving to contribute to this wonderful discussion on female empowerment in our profession, and ultimately how it relates to improving patient care! (Source: ASCP 2019 session 8012-19; Mulder, L., Upton, M., Vuhahula, E., Abedl AlThagafi, M., Papas, F., and Sanford, K.)
This year’s ASCP president, Dr. Melissa Upton moderated this
fantastic panel and opened with an old proverb: “If you want to go fast, go
alone. If you want to go far, go together.” This was definitely a theme for
each of the mini-sessions’ discussions. ASCP’s own Lotte Mulder discussed her
research on culturally applicable leadership training using her Leadership
Institute Initiative. She talked about countries that are culturally different
and developmentally different up and down the spectrum can all benefit from
leadership development and opportunity. Next came Dr. Edda Vuhahula, an
accomplished physician, educator, and advocate in Tanzania. She related her
experiences of women in leadership roles, and challenges on the horizon as more
women rise to these positions every day. Dr. Malak Abed AlThagafi talked about
her “hats:” as an entrepreneur, a medical director, and a researcher in her
whirlwind story of empowerment and accomplishment. Finally, medical laboratory
scientist and former Philippine Army colonel, Filipinas Papas gave her personal
perspectives on sexism, education, bias, and opportunity.
Celebrated my colleagues and my contributions to the 6thChoosing Wisely list of recommendations…
Figure 3. My totally biased favorite slide from Dr. Lee H. Hilbourne, chair of the ASCP Effective Test Utilization Steering Committee. It’s an honor to be included in this year’s list, alongside so many accomplished contributors.
The Choosing Wisely initiative, partnering with the
American Board of Internal Medicine and many other specialty organizations, is
one of my favorite programs at ASCP. To date, our lab medicine organization has
the highest number of effective test utilization recommendations. ASCP seeks
active contributions to our expanding lists of recommendations to eliminate
wasteful, unnecessary testing and to improve patient outcomes. This talk was
also a great opportunity to honor the ASCP 2019 Choosing Wisely
Champions: Dr. Gary W. Procop from the Cleveland Clinic, Dr. Lucy Nam from the
Inova Lab best practice team, and Dr. Alyssa Ziman from UCLA Health. Want to read
the most updated list of recommendations ASCP made to the Choosing Wisely initiative?
I watched some cutting-edge exchanges about cellular
therapy…
Image 2. Here I am with laboratorian S. Malakian and Dr. Gastineau with The Mayo Clinic after they discussed the future of complex cell therapies.
One really effective take-home message from this seminar was
that, if we’re going to rely on cellular therapy in the future—especially as it
relates to “individualized medicine”—then who do you think should be in charge?
Who’s got the most experience and knowledge when it comes to cell storage,
transfusion protocol, patient outcomes, and high reliability? Short answer:
it’s us. Long answer: go back and check out a piece
I wrote about high-stakes responsibility in and out of the lab!
Popped into fascinating hematologic cases at our
neighboring SHEAHP2019 meeting…
Listen, I like hematopathology, I’ll be the first to tell
you that. There were so many people giving presentations in this near
standing-room-only meeting, that I recognized from papers, abstracts, and
journals that I’ve read in the past year alone! There were so many interesting
sessions at this meeting, I wish I could have seen more…
Image 3. Here’s Dr. J. Dalland from Mayo Clinic Pathology discussing a lymphoproliferative disorder with associated eosinophilia. These talks go deep into morphology and photypic patterns, so that Hemepath colleagues have a chance to assess their workup and protocols. It’s also great learning for avoiding pitfalls—this case shows architectural changes in lymph nodes which could cause someone to misdiagnose!
Learned how to create an impactful dialogue with patients
directly…
What do you do as a pathologist when a patient wants to
speak to you? Yes, you. Not a typo! This was the last talk I went to and it was
a great way to close out this awesome conference.
Image 4. Me with (left to right) Dr. K. Sanford from VCU, Patient Champion Anthony Reed, Dr. M. Sitorius from the University of Nebraska, and M. Mitchell. All of these individuals had amazing things to say about bridging the gap between the bench and the bedside!
In their own ways these patient advocates demonstrated that
if you want to represent our lab profession as one of accuracy, answers, and
hope, we’ve got the skills and resources to do it! Dr. Sanford sees so many
patients in her transfusion services and discusses their care plans regularly.
Mr. Reed is an ASCP patient champion who, after being diagnosed with ESRD,
became a learned lab ally. Dr. Sitorius is a family medicine physician at a
pathology conference, talking about empathy and connection! Ms. Mitchell has
done fantastic work with her pathology colleagues after beating cancer and
fighting for patient education every day! These folks have taken our field of
laboratory medicine to its outer edges, touching patients’ lives directly—and I
left energized to take it further in the future.
And of course, I learned so much about the utilization of
social media as a practical tool for education, advocacy, and outreach…
I can’t list every single session, lecture, keynote,
presentation, or panel in this article. This was just a glimpse of what
meetings like this have to offer. You will learn, obviously, but you’ll also
gain access to new perspectives and meet people who reinvigorate your passion
for your profession in ways you didn’t even consider. One of the most
fulfilling experiences of this meeting was being on the ASCP Social Media Team!
Posting to Instagram, Facebook, and Twitter with the hashtags #ASCP2019,
#ASCPSoMeTeam, or the scavenger hunt #ASCPiSpy was a great way to bolster our
enthusiastic network. This was my third ASCP Annual Meeting, and I met so many
wonderful people I can’t wait for the next one! Here’s a few of my favorite
snaps from the meeting:
Image 5. Here’s part of our amazing #SocialMediaTeam: (left to right) A. Odegard from Baptist Health, myself, Dr. S. Mukhopadhyay from the Cleveland Clinic, Dr. A. Booth from the University of Texas, and Dr. K. Mirza from Loyola Chicago!Image 6. At my first ASCP meeting in California, Jeff Jacobs, ASCP’s Chief Science Officer, gave me some of the best advice for my own personal and professional growth, “Stay Humble” he told me. Nearly 5 years later, he added “Don’t Give Up” on goals, yourself, or anything in life. You can’t pick that up in a path review book. I feel lucky to know people like him.Image 7. #SoMe FTW (Social Media for the win!) At this great talk, Dr. C. Arnold, Dr. L. Shirley, and Dr. D. Gray III, all from the Ohio State University discussed how to use social media to build a reputation and expand your impact as a pathologist, educator, and advocate!Image 8: Conferences are a great time to run into old friends and colleagues whom you may have spent a month rotating with! If you read about my time at Danbury Hospital in Connecticut, Drs. O. Olayinka and G. Kuar were part of it and I’m glad to call them friends!Image 9: Presented by the ASCP Resident and Pathologist Councils, this was a great networking session to discuss fellowships, employment, and how to plan for the first 100 days of working in laboratory medicine from PGY-1 and on! I certainly learned a lot!Image 10: (left to right) Dr. K. Chaztopoulos from the Mayo Clinic, myself, and K.C. Booth, RN in front of his finalist poster in the scientific category! Another valuable professional connection and friend made through my experiences in laboratory medicine.Image 11. When one of your mentors (Dr. K. Mirza) is signing copies of The Pathologist magazine that featured him on the cover, you get in line for one …obviously.Image 12. Dr. M. Upton is an inspirational speaker and insightful individual both on stage and in person. She had words of encouragement for my upcoming residency interview season and made sure I felt I could rely on ASCP for whatever I needed professionally. Thank you, Dr. Upton!Image 13. Some more colleagues from Mayo Clinic Pathology (left to right): Dr. A. Ravindran, Dr. D. Larson, Dr. J. Dalland, and myself. These folks were very busy with all the great hematology sessions at the SHEAHP2019 meeting.Image 14: No ASCP Annual Meeting would be complete without the leadership, passion, and vision of our CEO Dr. Blair Holladay. He, his leadership team, and this organization have been integral in my path to pathology and I can’t wait to see what’s in store for the future!
Social media has become so valuable in our field. Not just
for networking, but sharing cases, impressions, publications, and more! It’s so
easy to rally behind a hashtag and support a cause in so many instances—why not
in our profession? Get involved, be an active voice for your own practice as
well as your colleagues.
If you want to learn more about the sessions you may have
missed, download the ASCP2019 app from the Apple App Store or Google App Store!
Thanks for reading! See you on social media, because when we
communicate and collaborate, we are #StrongerTogether! I’m on twitter at
@CKanakis, until next time!
–Constantine E. Kanakis MSc, MLS (ASCP)CM graduated from Loyola
University Chicago with a BS in Molecular Biology and Bioethics and then
Rush University with an MS in Medical Laboratory Science. He is
currently a medical student actively involved in public health and
laboratory medicine, conducting clinicals at Bronx-Care Hospital Center
in New York City.
Last
month we reviewed the different federal regulatory agencies responsible for
establishing laboratory testing guidelines, and a brief overview of the
different roles each department has. This month we’ll attempt to demystify
testing complexity (waived, non-waived, PPM) and why testing classification
matters. Still to come, we’ll review the optional accreditations available to
labs, and how accreditation differs from certification.
For all
in vitro diagnostic tests, the FDA is responsible for categorizing each test
based on their perceived complexity during the pre-market approval process.
From least to most complex, the categorizations are waived, moderate
complexity, and high complexity. The reason this is important is because with
each jump in test category, the CLIA rules associated with performing testing
will change – as will the permit designation required to perform testing. This
includes things such as QC requirements, validation testing, and personnel
requirements to define who can perform testing in the first place.
Waived tests are considered easy to use,
with little to no chance that the test result will provide wrong information or
cause harm if it is done incorrectly. This includes over-the-counter tests such
as home use urine pregnancy kits, where if the sample is applied incorrectly or
in insufficient volume there will simply be no result obtained at all. Many
Point of Care tests fall under this category, with testing performed in a wide
variety of locations including physician offices, urgent care clinics, imaging
centers and nursing homes. Locations performing waived testing only are still
required to obtain an appropriate CLIA Certificate of Waiver. (See the reference links at the end for a
list of all FDA approved CLIA-Waived tests.)
For
waived testing, laboratories must follow the manufacturer’s instructions for
testing, including the stated FDA approved intended use, without any deviation.
If the procedure is modified, or the test is used with specimens not approved
by the FDA – the complexity classification of the test will change from waived
to high complexity. A common situation where this occurs is with fingerstick
whole blood glucometers. Most device manufacturers on the market today for
point of care glucose testing are not FDA approved for use with
critically ill patients. Using these waived meters for patients deemed
“critically ill” based on your local institution’s designation would change the
complexity of testing from waived, to high, for this population of patients as
it would be considered “off-label use” – meaning you are using it against FDA
recommendations and approved forms of use for the test/instrument.
Another
caveat to be mindful of is your local state regulations. Certain states (NY,
especially) have very strict rules regarding testing complexity designation. In
NY, all tests performed within the same designated laboratory space will have
the same testing complexity designation. Meaning that if you have a moderate
complexity CBC analyzer in the same room you perform your waived urine
pregnancy tests – both are now considered moderate complexity. Even though
you’re following the manufacturer’s instructions for the pregnancy kit, using
only approved specimen types, and the kit is on the FDA approved CLIA-Waived list
– that test is now moderate complexity just because it is in the same room as
other higher complexity tests. That same pregnancy kit is considered waived
when kept separate in the emergency department, but becomes moderate complexity
(or higher) when used in the central laboratory.
Nonwaived tests refer to both moderate and
high complexity testing. After the FDA has approved a marketing submission,
their CLIA categorization of the test follows by utilizing a scorecard to grade
the test complexity on 7 different criteria. All phases of testing
(preanalytic, analytic and postanalytic) are evaluated in these steps:
Knowledge
– low scores require minimal scientific and technical knowledge to perform the
test, and knowledge needed can be easily obtained through on-the-job
instruction.
Training
& Experience – low scores require minimal training and limited experience
to perform the test.
Reagents
& Materials Preparation – low scores have stable and reliable reagents, and
require no special handling, precautions, or storage conditions. They typically
come prepackaged, premeasured, and ready for use; whereas high scores may
include manual steps such as volumetric measurements and/or reconstitution.
Characteristics
of Operational Steps – low scores have automatically executed steps (such as
dispensing specific volumes of sample/reagent, temperature monitoring, or
timing of steps); high scores require close monitoring or control, precise
temperatures or timing, accurate pipetting or extensive calculations.
Calibration,
Quality Control, and Proficiency Testing Materials – low scores have all
required reagents, controls and PT material commercially available and products
are stable.
Test
System Troubleshooting & Equipment Maintenance – low scores have automatic
troubleshooting or self-correction of errors (failed internal QC will
automatically repeat), or requires minimal judgement. Equipment maintenance
will be performed by the manufacturer or is minimal and easily performed,
whereas high scores require decision-making and direct intervention to resolve
most issues, or maintenance tasks require special skills and abilities.
Interpretation
& Judgement – low scores require minimal interpretation and judgement for
resolution of problems or determination of test results.
Low
scores indicate low complexity, with tests obtaining a total score of ≤12 being
categorized as moderate complexity. Tests with final scores >12 are
categorized as high complexity.
PPM: Within the category of nonwaived
tests is a subcategory referred to as Provider Performed Microscopy (PPM).
These are tests that are performed directly by a clinician during a patient
visit, and require the use of a microscope limited to bright-field or
phase-contrast microscopy. Based on the nature of the sample obtained, testing
must be performed immediately at the time of collection as delays could
compromise the accuracy of test results. As controls are typically not
commercially available for these tests, the testing is restricted to clinicians
only as knowledge and judgment is required to confirm testing accuracy and
correlation to the clinical presentation.
Tests
allowed under a PPM certificate are mostly related to OB/GYN procedures, with a
full list available through CMS here:
So the
next time you receive a request to add a new test at your laboratory, you’ll be
armed with a fairly long list of the requirements that come with that test
based on its complexity. Coming up next month we’ll discuss the difference
between laboratory certification and accreditation, along with the benefits of
obtaining accreditation for your lab.
-Kyle Nevins, MS, MLS(ASCP)CM is one of ASCP’s
2018 Top 5 in the 40 Under Forty recognition program. She has worked in
the medical laboratory profession for over 18 years. In her current
position, she transitions between performing laboratory audits across
the entire Northwell Health System on Long Island, NY, consulting for
at-risk laboratories outside of Northwell Health, bringing laboratories
up to regulatory standards, and acting as supervisor and mentor in labs
with management gaps.
There are multiple types of risk assessments required when
managing a laboratory safety program. OSHA’s Bloodborne and Airborne pathogens
standards require assessing the risk of employees’ exposure to particular lab
hazards. Risk assessments can be used to determine whether or not to add an
emergency eyewash station, and all lab chemicals need to be assessed for the
hazards they pose. These are just some assessments that are needed, and there
are particular steps to take when performing them. But what about the lab
emergency management plan? Should the lab perform a risk assessment for that?
The answer is yes, although the terminology used may be different. To prepare a
disaster readiness plan for the lab, the risk assessment that is needed is
known as a Hazard Vulnerability Analysis (HVA).
The Centers for Medicare & Medicaid Services (CMS)
requires that all healthcare facilities use an “all-hazards” approach when
considering emergency preparedness and planning. While some laboratories may be
included with the facility-wide disaster plan, the lab should absolutely have
its own plan with specific instructions that apply directly to the department.
That means the lab should also consider an all-hazards approach.
It may seem daunting to try to consider every possible
disaster that could occur in the department, but that is not exactly what the
directive from CMS dictates. An all-hazards approach means that emergency plans
should be scalable or flexible so that it can be used for many types of
disasters. The plan should focus on the lab’s ability to continue to offer
services, especially those deemed critical, as a disaster situation unfolds.
The first step to the plan creation is the risk assessment-
the Hazard Vulnerability Analysis. The HVA can be a table that lists all of the
potential types of disaster; natural, man-made, facility-specific, etc. List as
many as you can think of, and be sure to include specific disasters that may be
particular to your locale (earthquakes, blizzards, etc.). Rate each disaster
type by probability, severity of impact, and level of readiness of the lab to
respond. Using that data, you can calculate the risk percentage for each
emergency type.
One other requirement imposed by CMS is that facilities must
include emerging infectious diseases as one potential type of hazard class.
With the advent of particular diseases in the past years like Ebola, Zika, and
certain influenza types, it is important to consider how an outbreak would
affect lab operations and staffing. The risk level of infectious diseases may
vary as incidents and outbreaks occur in particular geographic regions or if
pandemics arise.
The HVA should be reviewed and updated as necessary each
year. Things change that can affect what is on your HVA list. The addition of a
nearby airport might make you consider adding airline disaster to the HVA. A
change in weather patterns could occur as well. In 2011 a surprise earthquake
in Virginia made state facilities re-look at their HVA list of possible emergency
situations. Also, the actual list of disasters might not change, but there may
be a change in the potential of a particular incident occurring.
If your lab or facility has not yet performed the HVA risk
assessment, there is no need to panic. There are several model HVA tools
available on line that can be used. As with any risk assessment, be sure to
keep documentation readily available, review it each year, and make sure staff
are trained about not only the HVA process, but in how to use the emergency
management plan as well. There is a great amount of work that can go into
preparing for a disaster, and training and drills for your staff will help to
facilitate a smoother activation of the plan when the real emergency situation
occurs.
–Dan Scungio, MT(ASCP), SLS, CQA (ASQ) has over 25 years
experience as a certified medical technologist. Today he is the
Laboratory Safety Officer for Sentara Healthcare, a system of seven
hospitals and over 20 laboratories and draw sites in the Tidewater area
of Virginia. He is also known as Dan the Lab Safety Man, a lab safety consultant, educator, and trainer.